2018 Startup GUIDE - 10th Edition
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
88 STARTUPS ON THE WAY TO SUCCESS<br />
AgroSustain<br />
Activating agriculture<br />
for sustainability<br />
ARTIRIA Medical<br />
A world’s first<br />
in stroke prevention<br />
TEAM<br />
AGRO-<br />
SUSTAIN<br />
TEAM<br />
ARTIRIA<br />
(Foto:<br />
Valentin Flauraud)<br />
Swiss agritech AgroSustain aims to reduce food<br />
wastage by developing and bringing to market efficient<br />
organic treatments against molds, a major flaw.<br />
Artiria develops a disruptive medical device allowing<br />
neuroradiologists to navigate in brain arteries faster<br />
and safer than any other available solution.<br />
AgroSustain develops novel organic treatments with broad antifungal<br />
properties that extend the freshness of fruits and vegetables<br />
during post-harvest by minimum one week, leading to significant<br />
food waste reduction.<br />
The start-up is the result of Dr. Olga Dubey’s PhD thesis at UNIL<br />
where the CEO & founder developed a novel screening approach<br />
for the identification of efficient antifungal compounds, followed<br />
by one year research at the Agroscope with support of InnoTREK<br />
& BRIDGE funding. Jean Pascal Aribot (co-founder, COO) – Strategic<br />
Business Developer & Sales Manager and PD. Dr. Sylvain<br />
Dubey (co-founder, CTO) – a passionate researcher with strong<br />
publication record – complete the founders team.<br />
Food & Agriculture Organization of the United Nations estimates<br />
annual food waste at an equivalent of CHF 1.3 trillion, out of which<br />
CHF 100 billions of fruits and vegetables get lost every year caused<br />
by fungal pathogens. Metabolites & some of the broadly spread<br />
fungi in food storage facilities can have additional negative effect<br />
on humans e.g. aflatoxin – poisonous carcinogen produced by Aspergillus<br />
species. To this day, no efficient, cost-effective, organic<br />
treatments against molds are available on the market.<br />
AgroSustain is ready to seize this market opportunity. The startup<br />
will be submitting its solution AgroShelf+ for toxicity tests as a<br />
pre-requisite for registration in Switzerland & internationally. The<br />
company also intends to secure further investment & initiate collaborations<br />
with food retailers & distributors to jointly drive waste<br />
reduction.<br />
AgroSustain | Epalinges | founded in <strong>2018</strong> | Agriculture<br />
technologies | Generated capital: CHF 550k |<br />
Supported by: BRIDGE, InnoTREK, Unil HEC accelerator,<br />
Venture Kick, Innosuisse, Venture, Prix cantonal<br />
Développement Durable Genève, La Forge, Center<br />
of Entrepreneurship University of St. Gallen, SPEI<br />
www.agrosustain.ch<br />
In the world an estimated 150M individuals live with an undiagnosed<br />
cerebral aneurysm, a weak spot in the wall of a cerebral artery.<br />
This silent killer develops over long time period & provokes<br />
most often irrevocable brain lesions when it ruptures (stroke; 51%<br />
of mortality/morbidity). The current best approach to prevent aneurysm<br />
from rupture (stroke) consists in endovascular surgeries.<br />
This minimally invasive image-guided technique allows reaching<br />
the brain arteries through the vascular system to fix cerebral lesions.<br />
However, the procedure can be drastically challenging to<br />
perform as access and navigation is delicate in brain vessels.<br />
Thanks to Artiria innovative product, a long and thin articulated<br />
endovascular wire, the surgeon can progress in the cerebrovascular<br />
system much faster and safer than with existing solution.<br />
This drastically improves the outcome of stroke-related procedures.<br />
Artiria’s technology is based on a micro-actuation mechanism<br />
which allows a precise control over the device tip shape,<br />
in real time, when inserted in the patient. The solution has been<br />
specifically designed to be well integrated in the current clinical<br />
practice, thanks to early partnerships with key opinion leaders in<br />
interventional neuroradiology.<br />
Artiria is currently focusing on the preclinical assessment of its<br />
product and is therefore preparing an in vivo trial by the end of<br />
the year. Achieving this milestones will bring the EPFL based startup<br />
to incorporation in order to raise the required 1st tranche (CHF<br />
3.5 M) of financing to proceed with the product industrialization,<br />
verification & clinical validation (human).<br />
ARTIRIA | Lausanne | founded in 2017 | Medtech<br />
| Supported by: Gebert Ruef Stiftung, EPFL Innogrants,<br />
BRIDGE, Venture Leaders Life Science,<br />
Venture, EPFL ENABLE<br />
www.artiria-medical.com<br />
SWISS STARTUP <strong>GUIDE</strong> <strong>2018</strong>
Change language